FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG) Article Swipe
Ali̇ Kalem
,
Tülay Kuş
,
Taha Koray Şahin
,
Ömer Dızdar
,
Safa Can Efil
,
Mehmet Alı Nahıt Şendur
,
Talat Aykut
,
Murat Araz
,
Hatice Bölek
,
Yüksel Ürün
,
Nadiye Sever
,
İbrahim Vedat Bayoğlu
,
Eyyüp Çavdar
,
muhammed Fatih Sağıroğlu
,
Tuğçe Kübra Güneş
,
Melike Özçelik
,
Nadide Demırel
,
Bülent Okan Yıldız
,
Berkan Karabuğa
,
Ülkü Yalçıntaş Arslan
,
Savaş Gökçek
,
İlkay Tuğba Ünek
,
Seray Saray
,
Ferit Aslan
,
Ömer Acar
,
Atike Pınar Erdoğan
,
Mustafa Seyyar
,
Gökmen Aktaş
,
Şuayib Yalçın
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.3390/cancers17172730
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.3390/cancers17172730
Background: Ampullary adenocarcinoma is a rare cancer for which there are no standard adjuvant treatment recommendations due to the lack of randomized clinical trials. The primary aim of this analysis is to investigate the efficacy of adjuvant FOLFIRINOX treatment in patients with resected ampullary adenocarcinoma. Materials and Methods: This multicenter retrospective cohort study was conducted at 15 institutions in Turkey between August 2007 and January 2024, involving 211 patients with resected, non-metastatic ampullary adenocarcinoma receiving adjuvant chemotherapy with various chemotherapy regimens with or without chemoradiation. Clinicopathological and treatment-related parameters were recorded. Disease-free survival (DFS) and overall survival (OS) were analyzed by using Kaplan–Meier estimates. Cox proportional hazards regression was used to identify covariates associated with OS. Results: The median follow-up time was 52 months, and 116 patients (55.2%) were alive at the time of the analysis. The median age was 61 years (32–82). mFOLFIRINOX was administered to 16.6% of the patients (n = 35). The 3-year DFS rate was 79.41% in the FOLFIRINOX-treated arm and 53.9% in the other treatment arm (p = 0.034 for mDFS). The median OS was non-reached in patients receiving mFOLFIRINOX treatment, while it was 51 months in patients receiving other treatments (p = 0.071). While no statistically significant results were reached, a trend toward statistically significant survival times was observed in the FOLFIRINOX arm. After adjustment for other prognostic parameters, mFOLFIRINOX remained an independent statistically significant parameter for better OS (HR; 95% CI: 3.24; 1.02–10.9; p = 0.046). Conclusions: FOLFIRINOX treatment has shown efficacy in the adjuvant treatment of ampullary cancer, independent of histological subtype. The findings should be validated in large prospective trials.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.3390/cancers17172730
- https://www.mdpi.com/2072-6694/17/17/2730/pdf?version=1755859560
- OA Status
- gold
- References
- 27
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4413411611
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4413411611Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.3390/cancers17172730Digital Object Identifier
- Title
-
FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG)Work title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-08-22Full publication date if available
- Authors
-
Ali̇ Kalem, Tülay Kuş, Taha Koray Şahin, Ömer Dızdar, Safa Can Efil, Mehmet Alı Nahıt Şendur, Talat Aykut, Murat Araz, Hatice Bölek, Yüksel Ürün, Nadiye Sever, İbrahim Vedat Bayoğlu, Eyyüp Çavdar, muhammed Fatih Sağıroğlu, Tuğçe Kübra Güneş, Melike Özçelik, Nadide Demırel, Bülent Okan Yıldız, Berkan Karabuğa, Ülkü Yalçıntaş Arslan, Savaş Gökçek, İlkay Tuğba Ünek, Seray Saray, Ferit Aslan, Ömer Acar, Atike Pınar Erdoğan, Mustafa Seyyar, Gökmen Aktaş, Şuayib YalçınList of authors in order
- Landing page
-
https://doi.org/10.3390/cancers17172730Publisher landing page
- PDF URL
-
https://www.mdpi.com/2072-6694/17/17/2730/pdf?version=1755859560Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://www.mdpi.com/2072-6694/17/17/2730/pdf?version=1755859560Direct OA link when available
- Concepts
-
Medicine, Turkish, Internal medicine, FOLFIRINOX, Oncology, Adjuvant, Adenocarcinoma, Multicenter study, Cancer, Irinotecan, Randomized controlled trial, Colorectal cancer, Linguistics, PhilosophyTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
27Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4413411611 |
|---|---|
| doi | https://doi.org/10.3390/cancers17172730 |
| ids.doi | https://doi.org/10.3390/cancers17172730 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40940827 |
| ids.openalex | https://openalex.org/W4413411611 |
| fwci | 0.0 |
| type | article |
| title | FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG) |
| biblio.issue | 17 |
| biblio.volume | 17 |
| biblio.last_page | 2730 |
| biblio.first_page | 2730 |
| topics[0].id | https://openalex.org/T10231 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 1.0 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Pancreatic and Hepatic Oncology Research |
| topics[1].id | https://openalex.org/T10449 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9959999918937683 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2740 |
| topics[1].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[1].display_name | Renal cell carcinoma treatment |
| topics[2].id | https://openalex.org/T10696 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9904999732971191 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Gastric Cancer Management and Outcomes |
| is_xpac | False |
| apc_list.value | 2400 |
| apc_list.currency | CHF |
| apc_list.value_usd | 2598 |
| apc_paid.value | 2400 |
| apc_paid.currency | CHF |
| apc_paid.value_usd | 2598 |
| concepts[0].id | https://openalex.org/C71924100 |
| concepts[0].level | 0 |
| concepts[0].score | 0.7300149202346802 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[0].display_name | Medicine |
| concepts[1].id | https://openalex.org/C2781121862 |
| concepts[1].level | 2 |
| concepts[1].score | 0.6671410799026489 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q256 |
| concepts[1].display_name | Turkish |
| concepts[2].id | https://openalex.org/C126322002 |
| concepts[2].level | 1 |
| concepts[2].score | 0.589771032333374 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[2].display_name | Internal medicine |
| concepts[3].id | https://openalex.org/C2777148230 |
| concepts[3].level | 5 |
| concepts[3].score | 0.5438241958618164 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q17144959 |
| concepts[3].display_name | FOLFIRINOX |
| concepts[4].id | https://openalex.org/C143998085 |
| concepts[4].level | 1 |
| concepts[4].score | 0.5070304870605469 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[4].display_name | Oncology |
| concepts[5].id | https://openalex.org/C2777863537 |
| concepts[5].level | 2 |
| concepts[5].score | 0.470193475484848 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q357896 |
| concepts[5].display_name | Adjuvant |
| concepts[6].id | https://openalex.org/C2781182431 |
| concepts[6].level | 3 |
| concepts[6].score | 0.4510570764541626 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q356033 |
| concepts[6].display_name | Adenocarcinoma |
| concepts[7].id | https://openalex.org/C2992435398 |
| concepts[7].level | 3 |
| concepts[7].score | 0.43835243582725525 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q6934595 |
| concepts[7].display_name | Multicenter study |
| concepts[8].id | https://openalex.org/C121608353 |
| concepts[8].level | 2 |
| concepts[8].score | 0.09073284268379211 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[8].display_name | Cancer |
| concepts[9].id | https://openalex.org/C2780259306 |
| concepts[9].level | 4 |
| concepts[9].score | 0.05206865072250366 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q412197 |
| concepts[9].display_name | Irinotecan |
| concepts[10].id | https://openalex.org/C168563851 |
| concepts[10].level | 2 |
| concepts[10].score | 0.05179598927497864 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q1436668 |
| concepts[10].display_name | Randomized controlled trial |
| concepts[11].id | https://openalex.org/C526805850 |
| concepts[11].level | 3 |
| concepts[11].score | 0.045341551303863525 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q188874 |
| concepts[11].display_name | Colorectal cancer |
| concepts[12].id | https://openalex.org/C41895202 |
| concepts[12].level | 1 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q8162 |
| concepts[12].display_name | Linguistics |
| concepts[13].id | https://openalex.org/C138885662 |
| concepts[13].level | 0 |
| concepts[13].score | 0.0 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q5891 |
| concepts[13].display_name | Philosophy |
| keywords[0].id | https://openalex.org/keywords/medicine |
| keywords[0].score | 0.7300149202346802 |
| keywords[0].display_name | Medicine |
| keywords[1].id | https://openalex.org/keywords/turkish |
| keywords[1].score | 0.6671410799026489 |
| keywords[1].display_name | Turkish |
| keywords[2].id | https://openalex.org/keywords/internal-medicine |
| keywords[2].score | 0.589771032333374 |
| keywords[2].display_name | Internal medicine |
| keywords[3].id | https://openalex.org/keywords/folfirinox |
| keywords[3].score | 0.5438241958618164 |
| keywords[3].display_name | FOLFIRINOX |
| keywords[4].id | https://openalex.org/keywords/oncology |
| keywords[4].score | 0.5070304870605469 |
| keywords[4].display_name | Oncology |
| keywords[5].id | https://openalex.org/keywords/adjuvant |
| keywords[5].score | 0.470193475484848 |
| keywords[5].display_name | Adjuvant |
| keywords[6].id | https://openalex.org/keywords/adenocarcinoma |
| keywords[6].score | 0.4510570764541626 |
| keywords[6].display_name | Adenocarcinoma |
| keywords[7].id | https://openalex.org/keywords/multicenter-study |
| keywords[7].score | 0.43835243582725525 |
| keywords[7].display_name | Multicenter study |
| keywords[8].id | https://openalex.org/keywords/cancer |
| keywords[8].score | 0.09073284268379211 |
| keywords[8].display_name | Cancer |
| keywords[9].id | https://openalex.org/keywords/irinotecan |
| keywords[9].score | 0.05206865072250366 |
| keywords[9].display_name | Irinotecan |
| keywords[10].id | https://openalex.org/keywords/randomized-controlled-trial |
| keywords[10].score | 0.05179598927497864 |
| keywords[10].display_name | Randomized controlled trial |
| keywords[11].id | https://openalex.org/keywords/colorectal-cancer |
| keywords[11].score | 0.045341551303863525 |
| keywords[11].display_name | Colorectal cancer |
| language | en |
| locations[0].id | doi:10.3390/cancers17172730 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S168415115 |
| locations[0].source.issn | 2072-6694 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2072-6694 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Cancers |
| locations[0].source.host_organization | https://openalex.org/P4310310987 |
| locations[0].source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310310987 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://www.mdpi.com/2072-6694/17/17/2730/pdf?version=1755859560 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Cancers |
| locations[0].landing_page_url | https://doi.org/10.3390/cancers17172730 |
| locations[1].id | pmid:40940827 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Cancers |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40940827 |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5090843246 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Ali̇ Kalem |
| authorships[0].countries | TR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I59738393 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Gaziantep University, Gaziantep 27310, Turkey |
| authorships[0].institutions[0].id | https://openalex.org/I59738393 |
| authorships[0].institutions[0].ror | https://ror.org/020vvc407 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I59738393 |
| authorships[0].institutions[0].country_code | TR |
| authorships[0].institutions[0].display_name | Gaziantep University |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ali Kalem |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Gaziantep University, Gaziantep 27310, Turkey |
| authorships[1].author.id | https://openalex.org/A5087227279 |
| authorships[1].author.orcid | https://orcid.org/0000-0001-5781-4820 |
| authorships[1].author.display_name | Tülay Kuş |
| authorships[1].countries | TR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I59738393 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Gaziantep University, Gaziantep 27310, Turkey |
| authorships[1].institutions[0].id | https://openalex.org/I59738393 |
| authorships[1].institutions[0].ror | https://ror.org/020vvc407 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I59738393 |
| authorships[1].institutions[0].country_code | TR |
| authorships[1].institutions[0].display_name | Gaziantep University |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Tulay Kus |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Gaziantep University, Gaziantep 27310, Turkey |
| authorships[2].author.id | https://openalex.org/A5032325513 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-3590-0426 |
| authorships[2].author.display_name | Taha Koray Şahin |
| authorships[2].countries | TR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I66514158 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Hacettepe University, Ankara 06100, Turkey |
| authorships[2].institutions[0].id | https://openalex.org/I66514158 |
| authorships[2].institutions[0].ror | https://ror.org/04kwvgz42 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I66514158 |
| authorships[2].institutions[0].country_code | TR |
| authorships[2].institutions[0].display_name | Hacettepe University |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Taha Koray Sahin |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Hacettepe University, Ankara 06100, Turkey |
| authorships[3].author.id | https://openalex.org/A5047643020 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-0911-9078 |
| authorships[3].author.display_name | Ömer Dızdar |
| authorships[3].countries | TR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I66514158 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Hacettepe University, Ankara 06100, Turkey |
| authorships[3].institutions[0].id | https://openalex.org/I66514158 |
| authorships[3].institutions[0].ror | https://ror.org/04kwvgz42 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I66514158 |
| authorships[3].institutions[0].country_code | TR |
| authorships[3].institutions[0].display_name | Hacettepe University |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Omer Dizdar |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Hacettepe University, Ankara 06100, Turkey |
| authorships[4].author.id | https://openalex.org/A5028291451 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-9586-2858 |
| authorships[4].author.display_name | Safa Can Efil |
| authorships[4].countries | TR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210150808 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Ankara YıldırımBeyazıt University, Ankara 06110, Turkey |
| authorships[4].institutions[0].id | https://openalex.org/I4210150808 |
| authorships[4].institutions[0].ror | https://ror.org/05ryemn72 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210150808 |
| authorships[4].institutions[0].country_code | TR |
| authorships[4].institutions[0].display_name | Ankara Yıldırım Beyazıt University |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Safa Can Efil |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Ankara YıldırımBeyazıt University, Ankara 06110, Turkey |
| authorships[5].author.id | https://openalex.org/A5052112651 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-7021-6139 |
| authorships[5].author.display_name | Mehmet Alı Nahıt Şendur |
| authorships[5].countries | TR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210150808 |
| authorships[5].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Ankara YıldırımBeyazıt University, Ankara 06110, Turkey |
| authorships[5].institutions[0].id | https://openalex.org/I4210150808 |
| authorships[5].institutions[0].ror | https://ror.org/05ryemn72 |
| authorships[5].institutions[0].type | education |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210150808 |
| authorships[5].institutions[0].country_code | TR |
| authorships[5].institutions[0].display_name | Ankara Yıldırım Beyazıt University |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Mehmet Ali Nahit Sendur |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Ankara YıldırımBeyazıt University, Ankara 06110, Turkey |
| authorships[6].author.id | https://openalex.org/A5007003860 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-9614-0651 |
| authorships[6].author.display_name | Talat Aykut |
| authorships[6].countries | TR |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I4210107659 |
| authorships[6].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Necmettin Erbakan University, Konya 42090, Turkey |
| authorships[6].institutions[0].id | https://openalex.org/I4210107659 |
| authorships[6].institutions[0].ror | https://ror.org/013s3zh21 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I4210107659 |
| authorships[6].institutions[0].country_code | TR |
| authorships[6].institutions[0].display_name | Necmettin Erbakan University |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Talat Aykut |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Necmettin Erbakan University, Konya 42090, Turkey |
| authorships[7].author.id | https://openalex.org/A5065251701 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-4632-9501 |
| authorships[7].author.display_name | Murat Araz |
| authorships[7].countries | TR |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I4210107659 |
| authorships[7].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Necmettin Erbakan University, Konya 42090, Turkey |
| authorships[7].institutions[0].id | https://openalex.org/I4210107659 |
| authorships[7].institutions[0].ror | https://ror.org/013s3zh21 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I4210107659 |
| authorships[7].institutions[0].country_code | TR |
| authorships[7].institutions[0].display_name | Necmettin Erbakan University |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Murat Araz |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Necmettin Erbakan University, Konya 42090, Turkey |
| authorships[8].author.id | https://openalex.org/A5028522949 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-8659-7327 |
| authorships[8].author.display_name | Hatice Bölek |
| authorships[8].countries | TR |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I149218525 |
| authorships[8].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Ankara University, Ankara 06230, Turkey |
| authorships[8].institutions[0].id | https://openalex.org/I149218525 |
| authorships[8].institutions[0].ror | https://ror.org/01wntqw50 |
| authorships[8].institutions[0].type | education |
| authorships[8].institutions[0].lineage | https://openalex.org/I149218525 |
| authorships[8].institutions[0].country_code | TR |
| authorships[8].institutions[0].display_name | Ankara University |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Hatice Bolek |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Ankara University, Ankara 06230, Turkey |
| authorships[9].author.id | https://openalex.org/A5067436525 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-9152-9887 |
| authorships[9].author.display_name | Yüksel Ürün |
| authorships[9].countries | TR |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I149218525 |
| authorships[9].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Ankara University, Ankara 06230, Turkey |
| authorships[9].institutions[0].id | https://openalex.org/I149218525 |
| authorships[9].institutions[0].ror | https://ror.org/01wntqw50 |
| authorships[9].institutions[0].type | education |
| authorships[9].institutions[0].lineage | https://openalex.org/I149218525 |
| authorships[9].institutions[0].country_code | TR |
| authorships[9].institutions[0].display_name | Ankara University |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Yuksel Urun |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Ankara University, Ankara 06230, Turkey |
| authorships[10].author.id | https://openalex.org/A5109760756 |
| authorships[10].author.orcid | |
| authorships[10].author.display_name | Nadiye Sever |
| authorships[10].countries | TR |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I74897591 |
| authorships[10].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Marmara University, İstanbul 34854, Turkey |
| authorships[10].institutions[0].id | https://openalex.org/I74897591 |
| authorships[10].institutions[0].ror | https://ror.org/02kswqa67 |
| authorships[10].institutions[0].type | education |
| authorships[10].institutions[0].lineage | https://openalex.org/I74897591 |
| authorships[10].institutions[0].country_code | TR |
| authorships[10].institutions[0].display_name | Marmara University |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Nadiye Sever |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Marmara University, İstanbul 34854, Turkey |
| authorships[11].author.id | https://openalex.org/A5002010642 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-0481-1084 |
| authorships[11].author.display_name | İbrahim Vedat Bayoğlu |
| authorships[11].countries | TR |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I74897591 |
| authorships[11].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Marmara University, İstanbul 34854, Turkey |
| authorships[11].institutions[0].id | https://openalex.org/I74897591 |
| authorships[11].institutions[0].ror | https://ror.org/02kswqa67 |
| authorships[11].institutions[0].type | education |
| authorships[11].institutions[0].lineage | https://openalex.org/I74897591 |
| authorships[11].institutions[0].country_code | TR |
| authorships[11].institutions[0].display_name | Marmara University |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Ibrahim Vedat Bayoglu |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Marmara University, İstanbul 34854, Turkey |
| authorships[12].author.id | https://openalex.org/A5080803322 |
| authorships[12].author.orcid | https://orcid.org/0000-0001-5885-3047 |
| authorships[12].author.display_name | Eyyüp Çavdar |
| authorships[12].countries | TR |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I198587356 |
| authorships[12].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Adıyaman Education and Research Hospital, Adıyaman 02100, Turkey |
| authorships[12].institutions[0].id | https://openalex.org/I198587356 |
| authorships[12].institutions[0].ror | https://ror.org/02s4gkg68 |
| authorships[12].institutions[0].type | education |
| authorships[12].institutions[0].lineage | https://openalex.org/I198587356 |
| authorships[12].institutions[0].country_code | TR |
| authorships[12].institutions[0].display_name | Adıyaman University |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Eyyup Cavdar |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Department of Medical Oncology, Adıyaman Education and Research Hospital, Adıyaman 02100, Turkey |
| authorships[13].author.id | https://openalex.org/A5034348467 |
| authorships[13].author.orcid | https://orcid.org/0000-0002-3253-6112 |
| authorships[13].author.display_name | muhammed Fatih Sağıroğlu |
| authorships[13].countries | TR |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I4210113973 |
| authorships[13].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Gaziantep City Hospital, Gaziantep 27470, Turkey |
| authorships[13].institutions[0].id | https://openalex.org/I4210113973 |
| authorships[13].institutions[0].ror | https://ror.org/0298vzs36 |
| authorships[13].institutions[0].type | healthcare |
| authorships[13].institutions[0].lineage | https://openalex.org/I4210113973 |
| authorships[13].institutions[0].country_code | TR |
| authorships[13].institutions[0].display_name | Medical Park Gaziantep Hospital |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Muhammed Fatih Sagıroglu |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Department of Medical Oncology, Gaziantep City Hospital, Gaziantep 27470, Turkey |
| authorships[14].author.id | https://openalex.org/A5109748014 |
| authorships[14].author.orcid | https://orcid.org/0000-0002-7917-2459 |
| authorships[14].author.display_name | Tuğçe Kübra Güneş |
| authorships[14].countries | TR |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210110321 |
| authorships[14].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Ümraniye Education and Research Hospital, İstanbul 34764, Turkey |
| authorships[14].institutions[0].id | https://openalex.org/I4210110321 |
| authorships[14].institutions[0].ror | https://ror.org/023wdy559 |
| authorships[14].institutions[0].type | healthcare |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210110321 |
| authorships[14].institutions[0].country_code | TR |
| authorships[14].institutions[0].display_name | Ümraniye Eğitim ve Araştırma Hastanesi |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Tugce Kubra Gunes |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | Department of Medical Oncology, Ümraniye Education and Research Hospital, İstanbul 34764, Turkey |
| authorships[15].author.id | https://openalex.org/A5067518254 |
| authorships[15].author.orcid | https://orcid.org/0000-0003-0406-715X |
| authorships[15].author.display_name | Melike Özçelik |
| authorships[15].countries | TR |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I4210110321 |
| authorships[15].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Ümraniye Education and Research Hospital, İstanbul 34764, Turkey |
| authorships[15].institutions[0].id | https://openalex.org/I4210110321 |
| authorships[15].institutions[0].ror | https://ror.org/023wdy559 |
| authorships[15].institutions[0].type | healthcare |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210110321 |
| authorships[15].institutions[0].country_code | TR |
| authorships[15].institutions[0].display_name | Ümraniye Eğitim ve Araştırma Hastanesi |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Melike Ozcelik |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Department of Medical Oncology, Ümraniye Education and Research Hospital, İstanbul 34764, Turkey |
| authorships[16].author.id | https://openalex.org/A5013571169 |
| authorships[16].author.orcid | https://orcid.org/0009-0001-4594-2398 |
| authorships[16].author.display_name | Nadide Demırel |
| authorships[16].countries | TR |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I51209816 |
| authorships[16].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Eskisehir Osmangazi University, Eskisehir 26040, Turkey |
| authorships[16].institutions[0].id | https://openalex.org/I51209816 |
| authorships[16].institutions[0].ror | https://ror.org/01dzjez04 |
| authorships[16].institutions[0].type | education |
| authorships[16].institutions[0].lineage | https://openalex.org/I51209816 |
| authorships[16].institutions[0].country_code | TR |
| authorships[16].institutions[0].display_name | Eskişehir Osmangazi University |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Nadide Demirel |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Eskisehir Osmangazi University, Eskisehir 26040, Turkey |
| authorships[17].author.id | https://openalex.org/A5040461677 |
| authorships[17].author.orcid | https://orcid.org/0000-0003-1797-7662 |
| authorships[17].author.display_name | Bülent Okan Yıldız |
| authorships[17].countries | TR |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I51209816 |
| authorships[17].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Eskisehir Osmangazi University, Eskisehir 26040, Turkey |
| authorships[17].institutions[0].id | https://openalex.org/I51209816 |
| authorships[17].institutions[0].ror | https://ror.org/01dzjez04 |
| authorships[17].institutions[0].type | education |
| authorships[17].institutions[0].lineage | https://openalex.org/I51209816 |
| authorships[17].institutions[0].country_code | TR |
| authorships[17].institutions[0].display_name | Eskişehir Osmangazi University |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Bulent Yıldız |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Eskisehir Osmangazi University, Eskisehir 26040, Turkey |
| authorships[18].author.id | https://openalex.org/A5041311126 |
| authorships[18].author.orcid | https://orcid.org/0000-0001-5357-7610 |
| authorships[18].author.display_name | Berkan Karabuğa |
| authorships[18].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Dr. AbdurrahmanYurtaslan Oncology Education and Research Hospital, Ankara 06200, Turkey |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Berkan Karabuga |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Department of Medical Oncology, Dr. AbdurrahmanYurtaslan Oncology Education and Research Hospital, Ankara 06200, Turkey |
| authorships[19].author.id | https://openalex.org/A5105514358 |
| authorships[19].author.orcid | https://orcid.org/0000-0001-5279-0903 |
| authorships[19].author.display_name | Ülkü Yalçıntaş Arslan |
| authorships[19].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Dr. AbdurrahmanYurtaslan Oncology Education and Research Hospital, Ankara 06200, Turkey |
| authorships[19].author_position | middle |
| authorships[19].raw_author_name | Ulku Yalcıntas Arslan |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Department of Medical Oncology, Dr. AbdurrahmanYurtaslan Oncology Education and Research Hospital, Ankara 06200, Turkey |
| authorships[20].author.id | https://openalex.org/A5093416880 |
| authorships[20].author.orcid | https://orcid.org/0000-0001-5928-0447 |
| authorships[20].author.display_name | Savaş Gökçek |
| authorships[20].countries | TR |
| authorships[20].affiliations[0].institution_ids | https://openalex.org/I193615760 |
| authorships[20].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Dokuz Eylul University, Izmir 35220, Turkey |
| authorships[20].institutions[0].id | https://openalex.org/I193615760 |
| authorships[20].institutions[0].ror | https://ror.org/00dbd8b73 |
| authorships[20].institutions[0].type | education |
| authorships[20].institutions[0].lineage | https://openalex.org/I193615760 |
| authorships[20].institutions[0].country_code | TR |
| authorships[20].institutions[0].display_name | Dokuz Eylül University |
| authorships[20].author_position | middle |
| authorships[20].raw_author_name | Savas Gokcek |
| authorships[20].is_corresponding | False |
| authorships[20].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Dokuz Eylul University, Izmir 35220, Turkey |
| authorships[21].author.id | https://openalex.org/A5076735539 |
| authorships[21].author.orcid | https://orcid.org/0000-0002-9124-6123 |
| authorships[21].author.display_name | İlkay Tuğba Ünek |
| authorships[21].countries | TR |
| authorships[21].affiliations[0].institution_ids | https://openalex.org/I193615760 |
| authorships[21].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Dokuz Eylul University, Izmir 35220, Turkey |
| authorships[21].institutions[0].id | https://openalex.org/I193615760 |
| authorships[21].institutions[0].ror | https://ror.org/00dbd8b73 |
| authorships[21].institutions[0].type | education |
| authorships[21].institutions[0].lineage | https://openalex.org/I193615760 |
| authorships[21].institutions[0].country_code | TR |
| authorships[21].institutions[0].display_name | Dokuz Eylül University |
| authorships[21].author_position | middle |
| authorships[21].raw_author_name | Ilkay Tugba Unek |
| authorships[21].is_corresponding | False |
| authorships[21].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Dokuz Eylul University, Izmir 35220, Turkey |
| authorships[22].author.id | https://openalex.org/A5010340021 |
| authorships[22].author.orcid | https://orcid.org/0000-0001-5916-6265 |
| authorships[22].author.display_name | Seray Saray |
| authorships[22].countries | TR |
| authorships[22].affiliations[0].institution_ids | https://openalex.org/I115600380 |
| authorships[22].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Ataturk Education and Research Hospital, Balıkesir 10100, Turkey |
| authorships[22].institutions[0].id | https://openalex.org/I115600380 |
| authorships[22].institutions[0].ror | https://ror.org/02tv7db43 |
| authorships[22].institutions[0].type | education |
| authorships[22].institutions[0].lineage | https://openalex.org/I115600380 |
| authorships[22].institutions[0].country_code | TR |
| authorships[22].institutions[0].display_name | Balıkesir University |
| authorships[22].author_position | middle |
| authorships[22].raw_author_name | Seray Saray |
| authorships[22].is_corresponding | False |
| authorships[22].raw_affiliation_strings | Department of Medical Oncology, Ataturk Education and Research Hospital, Balıkesir 10100, Turkey |
| authorships[23].author.id | https://openalex.org/A5057475586 |
| authorships[23].author.orcid | https://orcid.org/0000-0002-9153-6921 |
| authorships[23].author.display_name | Ferit Aslan |
| authorships[23].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Medical Park Ankara Batıkent Hospital, Ankara 06680, Turkey |
| authorships[23].author_position | middle |
| authorships[23].raw_author_name | Ferit Aslan |
| authorships[23].is_corresponding | False |
| authorships[23].raw_affiliation_strings | Department of Medical Oncology, Medical Park Ankara Batıkent Hospital, Ankara 06680, Turkey |
| authorships[24].author.id | https://openalex.org/A5028570951 |
| authorships[24].author.orcid | https://orcid.org/0000-0003-4408-1976 |
| authorships[24].author.display_name | Ömer Acar |
| authorships[24].countries | TR |
| authorships[24].affiliations[0].institution_ids | https://openalex.org/I16748637 |
| authorships[24].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Manisa Celal Bayar University, Manisa 45030, Turkey |
| authorships[24].institutions[0].id | https://openalex.org/I16748637 |
| authorships[24].institutions[0].ror | https://ror.org/053f2w588 |
| authorships[24].institutions[0].type | education |
| authorships[24].institutions[0].lineage | https://openalex.org/I16748637 |
| authorships[24].institutions[0].country_code | TR |
| authorships[24].institutions[0].display_name | Manisa Celal Bayar University |
| authorships[24].author_position | middle |
| authorships[24].raw_author_name | Omer Acar |
| authorships[24].is_corresponding | False |
| authorships[24].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Manisa Celal Bayar University, Manisa 45030, Turkey |
| authorships[25].author.id | https://openalex.org/A5030982886 |
| authorships[25].author.orcid | https://orcid.org/0000-0003-4859-7574 |
| authorships[25].author.display_name | Atike Pınar Erdoğan |
| authorships[25].countries | TR |
| authorships[25].affiliations[0].institution_ids | https://openalex.org/I16748637 |
| authorships[25].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Manisa Celal Bayar University, Manisa 45030, Turkey |
| authorships[25].institutions[0].id | https://openalex.org/I16748637 |
| authorships[25].institutions[0].ror | https://ror.org/053f2w588 |
| authorships[25].institutions[0].type | education |
| authorships[25].institutions[0].lineage | https://openalex.org/I16748637 |
| authorships[25].institutions[0].country_code | TR |
| authorships[25].institutions[0].display_name | Manisa Celal Bayar University |
| authorships[25].author_position | middle |
| authorships[25].raw_author_name | Atike Pınar Erdogan |
| authorships[25].is_corresponding | False |
| authorships[25].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Manisa Celal Bayar University, Manisa 45030, Turkey |
| authorships[26].author.id | https://openalex.org/A5061048010 |
| authorships[26].author.orcid | https://orcid.org/0000-0002-4841-7994 |
| authorships[26].author.display_name | Mustafa Seyyar |
| authorships[26].countries | TR |
| authorships[26].affiliations[0].institution_ids | https://openalex.org/I4210113973 |
| authorships[26].affiliations[0].raw_affiliation_string | Department of Medical Oncology, Gaziantep City Hospital, Gaziantep 27470, Turkey |
| authorships[26].institutions[0].id | https://openalex.org/I4210113973 |
| authorships[26].institutions[0].ror | https://ror.org/0298vzs36 |
| authorships[26].institutions[0].type | healthcare |
| authorships[26].institutions[0].lineage | https://openalex.org/I4210113973 |
| authorships[26].institutions[0].country_code | TR |
| authorships[26].institutions[0].display_name | Medical Park Gaziantep Hospital |
| authorships[26].author_position | middle |
| authorships[26].raw_author_name | Mustafa Seyyar |
| authorships[26].is_corresponding | False |
| authorships[26].raw_affiliation_strings | Department of Medical Oncology, Gaziantep City Hospital, Gaziantep 27470, Turkey |
| authorships[27].author.id | https://openalex.org/A5039600560 |
| authorships[27].author.orcid | https://orcid.org/0000-0003-4199-6943 |
| authorships[27].author.display_name | Gökmen Aktaş |
| authorships[27].countries | TR |
| authorships[27].affiliations[0].institution_ids | https://openalex.org/I4210113973 |
| authorships[27].affiliations[0].raw_affiliation_string | Gaziantep Medical Point Private Hospital, Gaziantep 27584, Turkey |
| authorships[27].institutions[0].id | https://openalex.org/I4210113973 |
| authorships[27].institutions[0].ror | https://ror.org/0298vzs36 |
| authorships[27].institutions[0].type | healthcare |
| authorships[27].institutions[0].lineage | https://openalex.org/I4210113973 |
| authorships[27].institutions[0].country_code | TR |
| authorships[27].institutions[0].display_name | Medical Park Gaziantep Hospital |
| authorships[27].author_position | middle |
| authorships[27].raw_author_name | Gokmen Aktas |
| authorships[27].is_corresponding | False |
| authorships[27].raw_affiliation_strings | Gaziantep Medical Point Private Hospital, Gaziantep 27584, Turkey |
| authorships[28].author.id | https://openalex.org/A5104062638 |
| authorships[28].author.orcid | |
| authorships[28].author.display_name | Şuayib Yalçın |
| authorships[28].countries | TR |
| authorships[28].affiliations[0].institution_ids | https://openalex.org/I66514158 |
| authorships[28].affiliations[0].raw_affiliation_string | Department of Medical Oncology, School of Medicine, Hacettepe University, Ankara 06100, Turkey |
| authorships[28].institutions[0].id | https://openalex.org/I66514158 |
| authorships[28].institutions[0].ror | https://ror.org/04kwvgz42 |
| authorships[28].institutions[0].type | education |
| authorships[28].institutions[0].lineage | https://openalex.org/I66514158 |
| authorships[28].institutions[0].country_code | TR |
| authorships[28].institutions[0].display_name | Hacettepe University |
| authorships[28].author_position | last |
| authorships[28].raw_author_name | Suayib Yalcın |
| authorships[28].is_corresponding | False |
| authorships[28].raw_affiliation_strings | Department of Medical Oncology, School of Medicine, Hacettepe University, Ankara 06100, Turkey |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://www.mdpi.com/2072-6694/17/17/2730/pdf?version=1755859560 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | FOLFIRINOX: The Best Adjuvant Treatment for Ampullary Adenocarcinoma? A Multicenter Study by the Turkish Oncology Group (TOG) |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10231 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 1.0 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Pancreatic and Hepatic Oncology Research |
| related_works | https://openalex.org/W3179919336, https://openalex.org/W2947666814, https://openalex.org/W1530374458, https://openalex.org/W2955230805, https://openalex.org/W2335789588, https://openalex.org/W4205173692, https://openalex.org/W2604532080, https://openalex.org/W2154339022, https://openalex.org/W2770177522, https://openalex.org/W2991183880 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.3390/cancers17172730 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S168415115 |
| best_oa_location.source.issn | 2072-6694 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2072-6694 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Cancers |
| best_oa_location.source.host_organization | https://openalex.org/P4310310987 |
| best_oa_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://www.mdpi.com/2072-6694/17/17/2730/pdf?version=1755859560 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Cancers |
| best_oa_location.landing_page_url | https://doi.org/10.3390/cancers17172730 |
| primary_location.id | doi:10.3390/cancers17172730 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S168415115 |
| primary_location.source.issn | 2072-6694 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2072-6694 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Cancers |
| primary_location.source.host_organization | https://openalex.org/P4310310987 |
| primary_location.source.host_organization_name | Multidisciplinary Digital Publishing Institute |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310310987 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://www.mdpi.com/2072-6694/17/17/2730/pdf?version=1755859560 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Cancers |
| primary_location.landing_page_url | https://doi.org/10.3390/cancers17172730 |
| publication_date | 2025-08-22 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W2064311046, https://openalex.org/W1995797355, https://openalex.org/W2064695797, https://openalex.org/W2999586332, https://openalex.org/W3103310815, https://openalex.org/W2994031807, https://openalex.org/W4389546009, https://openalex.org/W2125165403, https://openalex.org/W4383874849, https://openalex.org/W2782763130, https://openalex.org/W2903623792, https://openalex.org/W4381735887, https://openalex.org/W2151253787, https://openalex.org/W2947647349, https://openalex.org/W3157925591, https://openalex.org/W1982377568, https://openalex.org/W1980211776, https://openalex.org/W2115812130, https://openalex.org/W2943186250, https://openalex.org/W2000085538, https://openalex.org/W2115261608, https://openalex.org/W2129754451, https://openalex.org/W4238301033, https://openalex.org/W2138985803, https://openalex.org/W2581973599, https://openalex.org/W2614912850, https://openalex.org/W4403789061 |
| referenced_works_count | 27 |
| abstract_inverted_index.= | 152, 172, 197, 241 |
| abstract_inverted_index.a | 4, 206 |
| abstract_inverted_index.p | 240 |
| abstract_inverted_index.(n | 151 |
| abstract_inverted_index.(p | 171, 196 |
| abstract_inverted_index.15 | 56 |
| abstract_inverted_index.51 | 189 |
| abstract_inverted_index.52 | 122 |
| abstract_inverted_index.61 | 140 |
| abstract_inverted_index.OS | 178, 234 |
| abstract_inverted_index.an | 227 |
| abstract_inverted_index.at | 55, 130 |
| abstract_inverted_index.be | 263 |
| abstract_inverted_index.by | 100 |
| abstract_inverted_index.in | 39, 58, 160, 166, 181, 191, 215, 249, 265 |
| abstract_inverted_index.is | 3, 30 |
| abstract_inverted_index.it | 187 |
| abstract_inverted_index.no | 11, 200 |
| abstract_inverted_index.of | 20, 27, 35, 133, 148, 253, 257 |
| abstract_inverted_index.or | 82 |
| abstract_inverted_index.to | 17, 31, 110, 146 |
| abstract_inverted_index.116 | 125 |
| abstract_inverted_index.211 | 67 |
| abstract_inverted_index.95% | 236 |
| abstract_inverted_index.CI: | 237 |
| abstract_inverted_index.Cox | 104 |
| abstract_inverted_index.DFS | 156 |
| abstract_inverted_index.OS. | 115 |
| abstract_inverted_index.The | 24, 117, 136, 154, 176, 260 |
| abstract_inverted_index.age | 138 |
| abstract_inverted_index.aim | 26 |
| abstract_inverted_index.and | 46, 63, 86, 94, 124, 164 |
| abstract_inverted_index.are | 10 |
| abstract_inverted_index.arm | 163, 170 |
| abstract_inverted_index.due | 16 |
| abstract_inverted_index.for | 7, 174, 221, 232 |
| abstract_inverted_index.has | 246 |
| abstract_inverted_index.the | 18, 33, 131, 134, 149, 161, 167, 216, 250 |
| abstract_inverted_index.was | 53, 108, 121, 139, 144, 158, 179, 188, 213 |
| abstract_inverted_index.(HR; | 235 |
| abstract_inverted_index.(OS) | 97 |
| abstract_inverted_index.2007 | 62 |
| abstract_inverted_index.35). | 153 |
| abstract_inverted_index.This | 48 |
| abstract_inverted_index.arm. | 218 |
| abstract_inverted_index.lack | 19 |
| abstract_inverted_index.rare | 5 |
| abstract_inverted_index.rate | 157 |
| abstract_inverted_index.this | 28 |
| abstract_inverted_index.time | 120, 132 |
| abstract_inverted_index.used | 109 |
| abstract_inverted_index.were | 89, 98, 128, 204 |
| abstract_inverted_index.with | 41, 69, 77, 81, 114 |
| abstract_inverted_index.(DFS) | 93 |
| abstract_inverted_index.0.034 | 173 |
| abstract_inverted_index.16.6% | 147 |
| abstract_inverted_index.2024, | 65 |
| abstract_inverted_index.3.24; | 238 |
| abstract_inverted_index.53.9% | 165 |
| abstract_inverted_index.After | 219 |
| abstract_inverted_index.While | 199 |
| abstract_inverted_index.alive | 129 |
| abstract_inverted_index.large | 266 |
| abstract_inverted_index.other | 168, 194, 222 |
| abstract_inverted_index.shown | 247 |
| abstract_inverted_index.study | 52 |
| abstract_inverted_index.there | 9 |
| abstract_inverted_index.times | 212 |
| abstract_inverted_index.trend | 207 |
| abstract_inverted_index.using | 101 |
| abstract_inverted_index.which | 8 |
| abstract_inverted_index.while | 186 |
| abstract_inverted_index.years | 141 |
| abstract_inverted_index.3-year | 155 |
| abstract_inverted_index.79.41% | 159 |
| abstract_inverted_index.August | 61 |
| abstract_inverted_index.Turkey | 59 |
| abstract_inverted_index.better | 233 |
| abstract_inverted_index.cancer | 6 |
| abstract_inverted_index.cohort | 51 |
| abstract_inverted_index.mDFS). | 175 |
| abstract_inverted_index.median | 118, 137, 177 |
| abstract_inverted_index.months | 190 |
| abstract_inverted_index.should | 262 |
| abstract_inverted_index.toward | 208 |
| abstract_inverted_index.(55.2%) | 127 |
| abstract_inverted_index.0.046). | 242 |
| abstract_inverted_index.0.071). | 198 |
| abstract_inverted_index.January | 64 |
| abstract_inverted_index.between | 60 |
| abstract_inverted_index.cancer, | 255 |
| abstract_inverted_index.hazards | 106 |
| abstract_inverted_index.months, | 123 |
| abstract_inverted_index.overall | 95 |
| abstract_inverted_index.primary | 25 |
| abstract_inverted_index.results | 203 |
| abstract_inverted_index.trials. | 23, 268 |
| abstract_inverted_index.various | 78 |
| abstract_inverted_index.without | 83 |
| abstract_inverted_index.Methods: | 47 |
| abstract_inverted_index.Results: | 116 |
| abstract_inverted_index.adjuvant | 13, 36, 75, 251 |
| abstract_inverted_index.analysis | 29 |
| abstract_inverted_index.analyzed | 99 |
| abstract_inverted_index.clinical | 22 |
| abstract_inverted_index.efficacy | 34, 248 |
| abstract_inverted_index.findings | 261 |
| abstract_inverted_index.identify | 111 |
| abstract_inverted_index.observed | 214 |
| abstract_inverted_index.patients | 40, 68, 126, 150, 182, 192 |
| abstract_inverted_index.reached, | 205 |
| abstract_inverted_index.regimens | 80 |
| abstract_inverted_index.remained | 226 |
| abstract_inverted_index.resected | 42 |
| abstract_inverted_index.standard | 12 |
| abstract_inverted_index.subtype. | 259 |
| abstract_inverted_index.survival | 92, 96, 211 |
| abstract_inverted_index.Ampullary | 1 |
| abstract_inverted_index.Materials | 45 |
| abstract_inverted_index.ampullary | 43, 72, 254 |
| abstract_inverted_index.analysis. | 135 |
| abstract_inverted_index.conducted | 54 |
| abstract_inverted_index.follow-up | 119 |
| abstract_inverted_index.involving | 66 |
| abstract_inverted_index.parameter | 231 |
| abstract_inverted_index.receiving | 74, 183, 193 |
| abstract_inverted_index.recorded. | 90 |
| abstract_inverted_index.resected, | 70 |
| abstract_inverted_index.treatment | 14, 38, 169, 245, 252 |
| abstract_inverted_index.validated | 264 |
| abstract_inverted_index.(32–82). | 142 |
| abstract_inverted_index.FOLFIRINOX | 37, 217, 244 |
| abstract_inverted_index.adjustment | 220 |
| abstract_inverted_index.associated | 113 |
| abstract_inverted_index.covariates | 112 |
| abstract_inverted_index.estimates. | 103 |
| abstract_inverted_index.parameters | 88 |
| abstract_inverted_index.prognostic | 223 |
| abstract_inverted_index.randomized | 21 |
| abstract_inverted_index.regression | 107 |
| abstract_inverted_index.treatment, | 185 |
| abstract_inverted_index.treatments | 195 |
| abstract_inverted_index.Background: | 0 |
| abstract_inverted_index.independent | 228, 256 |
| abstract_inverted_index.investigate | 32 |
| abstract_inverted_index.mFOLFIRINOX | 143, 184, 225 |
| abstract_inverted_index.multicenter | 49 |
| abstract_inverted_index.non-reached | 180 |
| abstract_inverted_index.parameters, | 224 |
| abstract_inverted_index.prospective | 267 |
| abstract_inverted_index.significant | 202, 210, 230 |
| abstract_inverted_index.1.02–10.9; | 239 |
| abstract_inverted_index.Conclusions: | 243 |
| abstract_inverted_index.Disease-free | 91 |
| abstract_inverted_index.administered | 145 |
| abstract_inverted_index.chemotherapy | 76, 79 |
| abstract_inverted_index.histological | 258 |
| abstract_inverted_index.institutions | 57 |
| abstract_inverted_index.proportional | 105 |
| abstract_inverted_index.retrospective | 50 |
| abstract_inverted_index.statistically | 201, 209, 229 |
| abstract_inverted_index.Kaplan–Meier | 102 |
| abstract_inverted_index.adenocarcinoma | 2, 73 |
| abstract_inverted_index.non-metastatic | 71 |
| abstract_inverted_index.adenocarcinoma. | 44 |
| abstract_inverted_index.chemoradiation. | 84 |
| abstract_inverted_index.recommendations | 15 |
| abstract_inverted_index.treatment-related | 87 |
| abstract_inverted_index.FOLFIRINOX-treated | 162 |
| abstract_inverted_index.Clinicopathological | 85 |
| cited_by_percentile_year | |
| corresponding_author_ids | https://openalex.org/A5090843246 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 29 |
| corresponding_institution_ids | https://openalex.org/I59738393 |
| citation_normalized_percentile.value | 0.49307198 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |